SS18 and myopathy: Importantly, the induction of SS18-SSX2 expression through Hprt-Cre, Pax3-Cre, or Pax7-Cre resulted in embryonic lethality, while SS18-SSX2 activation in Myf6-expressing myocytes or myofibers resulted in myopathy but no tumors.